BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ploenes T, Scholtes B, Krohn A, Burger M, Passlick B, Müller-Quernheim J, Zissel G. CC-chemokine ligand 18 induces epithelial to mesenchymal transition in lung cancer A549 cells and elevates the invasive potential. PLoS One. 2013;8:e53068. [PMID: 23349697 DOI: 10.1371/journal.pone.0053068] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Korbecki J, Grochans S, Gutowska I, Barczak K, Baranowska-Bosiacka I. CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands. Int J Mol Sci. 2020;21. [PMID: 33076281 DOI: 10.3390/ijms21207619] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
2 Panda S, Padhiary SK, Routray S. Chemokines accentuating protumoral activities in oral cancer microenvironment possess an imperious stratagem for therapeutic resolutions. Oral Oncol 2016;60:8-17. [PMID: 27531867 DOI: 10.1016/j.oraloncology.2016.06.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
3 Liu YN, Chang TH, Tsai MF, Wu SG, Tsai TH, Chen HY, Yu SL, Yang JC, Shih JY. IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer. Oncotarget 2015;6:10415-31. [PMID: 25871388 DOI: 10.18632/oncotarget.3389] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
4 Song H, Tao Y, Ni N, Zhou X, Xiong J, Zeng X, Xu X, Qi J, Sun J. miR-128 targets the CC chemokine ligand 18 gene (CCL18) in cutaneous malignant melanoma progression. Journal of Dermatological Science 2018;91:317-24. [DOI: 10.1016/j.jdermsci.2018.06.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
5 Jiang X, Wang J, Chen X, Hong Y, Wu T, Chen X, Xia J, Cheng B. Elevated autocrine chemokine ligand 18 expression promotes oral cancer cell growth and invasion via Akt activation. Oncotarget 2016;7:16262-72. [PMID: 26919103 DOI: 10.18632/oncotarget.7585] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
6 Yang XL, Liu KY, Lin FJ, Shi HM, Ou ZL. CCL28 promotes breast cancer growth and metastasis through MAPK-mediated cellular anti-apoptosis and pro-metastasis. Oncol Rep 2017;38:1393-401. [PMID: 28713975 DOI: 10.3892/or.2017.5798] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
7 Plönes T, Fischer M, Höhne K, Sato H, Müller-Quernheim J, Zissel G. Turning back the Wheel: Inducing Mesenchymal to Epithelial Transition via Wilms Tumor 1 Knockdown in Human Mesothelioma Cell Lines to Influence Proliferation, Invasiveness, and Chemotaxis. Pathol Oncol Res 2017;23:723-30. [PMID: 28054314 DOI: 10.1007/s12253-016-0181-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
8 Loyher P, Rodero MP, Combadière C, Boissonnas A. Role of Chemokines and Chemokine Receptors in Cancer. In: Rezaei N, editor. Cancer Immunology. Cham: Springer International Publishing; 2020. pp. 235-62. [DOI: 10.1007/978-3-030-30845-2_14] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
9 Davis LE, Jeng S, Svalina MN, Huang E, Pittsenbarger J, Cantor EL, Berlow N, Seguin B, Mansoor A, McWeeney SK, Keller C. Integration of genomic, transcriptomic and functional profiles of aggressive osteosarcomas across multiple species. Oncotarget 2017;8:76241-56. [PMID: 29100308 DOI: 10.18632/oncotarget.19532] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
10 Zhang C, Yuan J, Hu H, Chen W, Liu M, Zhang J, Sun S, Guo Z. Long non-coding RNA CHCHD4P4 promotes epithelial-mesenchymal transition and inhibits cell proliferation in calcium oxalate-induced kidney damage. Braz J Med Biol Res 2017;51:e6536. [PMID: 29160413 DOI: 10.1590/1414-431X20176536] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
11 Hou KZ, Fu ZQ, Gong H. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition. World J Gastroenterol 2015; 21(2): 475-483 [PMID: 25593462 DOI: 10.3748/wjg.v21.i2.475] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
12 Gkika E, Vach W, Adebahr S, Schimek-Jasch T, Brenner A, Brunner TB, Kaier K, Prasse A, Müller-Quernheim J, Grosu AL, Zissel G, Nestle U. Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)? PLoS One 2017;12:e0185350. [PMID: 28957436 DOI: 10.1371/journal.pone.0185350] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
13 Saijo A, Goto H, Nakano M, Mitsuhashi A, Aono Y, Hanibuchi M, Ogawa H, Uehara H, Kondo K, Nishioka Y. Bone marrow-derived fibrocytes promote stem cell-like properties of lung cancer cells. Cancer Lett 2018;421:17-27. [PMID: 29448000 DOI: 10.1016/j.canlet.2018.02.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
14 Rodero MP, Combadière C, Boissonnas A. Role of Chemokines and Chemokine Receptors in Cancer. In: Rezaei N, editor. Cancer Immunology. Berlin: Springer Berlin Heidelberg; 2015. pp. 121-42. [DOI: 10.1007/978-3-662-44006-3_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Kong S, Ding L, Fan C, Li Y, Wang C, Wang K, Xu W, Shi X, Wu Q, Wang F. Global analysis of lysine acetylome reveals the potential role of CCL18 in non-small cell lung cancer. Proteomics 2021;21:e2000144. [PMID: 33570763 DOI: 10.1002/pmic.202000144] [Reference Citation Analysis]
16 Hou X, Zhang Y, Qiao H. CCL18 promotes the invasion and migration of gastric cancer cells via ERK1/2/NF-κB signaling pathway. Tumour Biol. 2016;37:641-651. [PMID: 26242263 DOI: 10.1007/s13277-015-3825-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
17 Lin L, Chen YS, Yao YD, Chen JQ, Chen JN, Huang SY, Zeng YJ, Yao HR, Zeng SH, Fu YS, Song EW. CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer. Oncotarget. 2015;6:34758-34773. [PMID: 26416449 DOI: 10.18632/oncotarget.5325] [Cited by in Crossref: 86] [Cited by in F6Publishing: 88] [Article Influence: 17.2] [Reference Citation Analysis]
18 Korbecki J, Olbromski M, Dzięgiel P. CCL18 in the Progression of Cancer. Int J Mol Sci 2020;21:E7955. [PMID: 33114763 DOI: 10.3390/ijms21217955] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
19 Reyes ME, de La Fuente M, Hermoso M, Ili CG, Brebi P. Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer. Front Immunol 2020;11:901. [PMID: 32499779 DOI: 10.3389/fimmu.2020.00901] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
20 Hector A, Kröner C, Carevic M, Bakele M, Rieber N, Riethmüller J, Griese M, Zissel G, Hartl D. The chemokine CCL18 characterises Pseudomonas infections in cystic fibrosis lung disease. Eur Respir J 2014;44:1608-15. [PMID: 25142483 DOI: 10.1183/09031936.00070014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
21 Foster JG, Wong SC, Sharp TV. The hypoxic tumor microenvironment: driving the tumorigenesis of non-small-cell lung cancer. Future Oncol 2014;10:2659-74. [PMID: 25531051 DOI: 10.2217/fon.14.201] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
22 Vallo S, Rutz J, Kautsch M, Winkelmann R, Michaelis M, Wezel F, Bartsch G, Haferkamp A, Rothweiler F, Blaheta RA, Cinatl J Jr. Blocking integrin β1 decreases adhesion in chemoresistant urothelial cancer cell lines. Oncol Lett 2017;14:5513-8. [PMID: 29113179 DOI: 10.3892/ol.2017.6883] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
23 Chenivesse C, Tsicopoulos A. CCL18 - Beyond chemotaxis. Cytokine 2018;109:52-6. [PMID: 29402725 DOI: 10.1016/j.cyto.2018.01.023] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
24 Duan R, Zhang Y, van Dijk L, Barbieri D, van den Beucken J, Yuan H, de Bruijn J. Coupling between macrophage phenotype, angiogenesis and bone formation by calcium phosphates. Mater Sci Eng C Mater Biol Appl 2021;122:111948. [PMID: 33641931 DOI: 10.1016/j.msec.2021.111948] [Reference Citation Analysis]
25 Ma Z, Ma C, Zhang Q, Bai Y, Mu K, Liu X, Yang Q. Role of CXCL16 in BLM-induced epithelial-mesenchymal transition in human A549 cells. Respir Res 2021;22:42. [PMID: 33549109 DOI: 10.1186/s12931-021-01646-7] [Reference Citation Analysis]
26 Dhoke NR, Kalabathula E, Kaushik K, Geesala R, Sravani B, Das A. Histone deacetylases differentially regulate the proliferative phenotype of mouse bone marrow stromal and hematopoietic stem/progenitor cells. Stem Cell Research 2016;17:170-80. [DOI: 10.1016/j.scr.2016.07.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
27 Ossorio M, Martínez V, Bajo MA, Del Peso G, Castro MJ, Romero S, Selgas R, Bellón T. Prominent Levels of the Profibrotic Chemokine CCL18 during Peritonitis: In Vitro Downregulation by Vitamin D Receptor Agonists. Biomed Res Int 2018;2018:6415892. [PMID: 29850544 DOI: 10.1155/2018/6415892] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Cardoso AP, Pinto ML, Castro F, Costa ÂM, Marques-Magalhães Â, Canha-Borges A, Cruz T, Velho S, Oliveira MJ. The immunosuppressive and pro-tumor functions of CCL18 at the tumor microenvironment. Cytokine Growth Factor Rev 2021;60:107-19. [PMID: 33863622 DOI: 10.1016/j.cytogfr.2021.03.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Wang H, Liang X, Li M, Tao X, Tai S, Fan Z, Wang Z, Cheng B, Xia J. Chemokine (CC motif) ligand 18 upregulates Slug expression to promote stem-cell like features by activating the mammalian target of rapamycin pathway in oral squamous cell carcinoma. Cancer Sci 2017;108:1584-93. [PMID: 28574664 DOI: 10.1111/cas.13289] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]